Race/ethnicity, serum 25-hydroxyvitamin D, and heart disease

JAMA

Volumn 310, Issue 2, 2013, Pages 153-154

  Norris, Keith C ^a,b   Williams, Sandra F ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ANGINA PECTORIS; ASIAN; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; ETHNIC DIFFERENCE; ETHNICITY; HEART DEATH; HEART DISEASE; HEART INFARCTION; HISPANIC; HUMAN; NEGRO; NONHUMAN; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; RISK FACTOR; VITAMIN BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; ETHNOLOGY; FEMALE; MALE; NOTE;

CORONARY DISEASE; FEMALE; HUMANS; MALE; VITAMIN D;

EID: 84880172881     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.7229     Document Type: Editorial

References (12)

1. Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS. Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011;19(4):192-201.
2. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc. 2010;11(9):617-628.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
4. Institute of Medicine of the National Academy of Sciences. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: Institute of Medicine of the National Academy of Sciences; 2010.
5. Robinson-Cohen C, Hoofnagle AN, Ix JH, et al.Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013;310(2):179-188.
6. Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779-785.
7. Sokol SI, Srinivas V, Crandall JP, et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med. 2012;17(6):394-404.
8. Valiña-Tóth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, Flack JM. Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf). 2010;72(5):595-603.
9. Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension. 2010;56(5):774-779.
10. Chun RF, Adams JS, Hewison M. Back to the future: a new look at "old" vitamin D. J Endocrinol. 2008;198(2):261-269.
11. Artaza JN, Contreras S, Garcia LA, et al. Vitamin D and cardiovascular disease: potential role in health disparities. J Health Care Poor Underserved. 2011;22(4)(suppl):23-38.
12. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res. 2010;54(8):1103-1113.